Immune-modulation research
Thymosin Alpha-1.
N-terminally acetylated 28-residue peptide derived from prothymosin alpha. Researched for T-cell maturation pathways. Marketed in some countries as Zadaxin (Italy, Mexico, China) under prescription; research-peptide formulations are not approved for human therapeutic use.
Long-form research guide
Immunity Enhancement Research. Mechanism + protocols + safety.
T-cell modulation, innate immunity, and adjuvant effects in preclinical models
Open the long-form guide for Thymosin Alpha-1 →